Double Medical Technology Inc. (002901.SZ)
CNY 30.74
(-0.03%)
CNY 30.74
(-0.03%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 301.61 Million CNY | -21.02% |
| 2022 | 246.06 Million CNY | -71.49% |
| 2021 | 873.91 Million CNY | 16.4% |
| 2020 | 759.05 Million CNY | 27.0% |
| 2019 | 591.65 Million CNY | 27.4% |
| 2018 | 441.53 Million CNY | 24.9% |
| 2017 | 375.58 Million CNY | 43.55% |
| 2016 | 287.53 Million CNY | 11.95% |
| 2015 | 237.7 Million CNY | 27.26% |
| 2014 | 180.05 Million CNY | 73.88% |
| 2013 | 107.33 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 82.11 Million CNY | 221.45% |
| 2024 Q2 | 122.51 Million CNY | 81.63% |
| 2024 Q3 | 125.6 Million CNY | -12.13% |
| 2023 Q3 | 18.68 Million CNY | -51.24% |
| 2023 Q4 | -8.66 Million CNY | -146.4% |
| 2023 Q1 | 75.53 Million CNY | 170.77% |
| 2023 FY | - CNY | -21.02% |
| 2023 Q2 | 38.32 Million CNY | -49.26% |
| 2022 Q4 | -106.72 Million CNY | -311.94% |
| 2022 Q3 | 50.35 Million CNY | -42.18% |
| 2022 Q2 | 87.09 Million CNY | -32.89% |
| 2022 Q1 | 129.77 Million CNY | -52.75% |
| 2022 FY | - CNY | -71.49% |
| 2021 Q4 | 274.64 Million CNY | 60.03% |
| 2021 Q3 | 171.62 Million CNY | -24.73% |
| 2021 FY | - CNY | 16.4% |
| 2021 Q1 | 152.78 Million CNY | -27.06% |
| 2021 Q2 | 228 Million CNY | 49.24% |
| 2020 Q2 | 221.22 Million CNY | 121.43% |
| 2020 Q3 | 197.35 Million CNY | -10.79% |
| 2020 FY | - CNY | 27.0% |
| 2020 Q1 | 99.9 Million CNY | -36.89% |
| 2020 Q4 | 209.47 Million CNY | 6.14% |
| 2019 Q2 | 150.55 Million CNY | 36.1% |
| 2019 FY | - CNY | 27.4% |
| 2019 Q1 | 110.61 Million CNY | -23.47% |
| 2019 Q4 | 158.31 Million CNY | 4.01% |
| 2019 Q3 | 152.2 Million CNY | 1.1% |
| 2018 Q4 | 144.53 Million CNY | 29.7% |
| 2018 Q1 | 85.95 Million CNY | -16.85% |
| 2018 Q3 | 111.43 Million CNY | -8.12% |
| 2018 Q2 | 121.28 Million CNY | 41.11% |
| 2018 FY | - CNY | 24.9% |
| 2017 Q1 | 74.57 Million CNY | 38.81% |
| 2017 FY | - CNY | 43.55% |
| 2017 Q4 | 103.36 Million CNY | 4.87% |
| 2017 Q3 | 98.56 Million CNY | 28.28% |
| 2017 Q2 | 76.83 Million CNY | 3.03% |
| 2016 Q3 | 75.47 Million CNY | 0.0% |
| 2016 FY | - CNY | 11.95% |
| 2016 Q4 | 53.72 Million CNY | -28.82% |
| 2015 FY | - CNY | 27.26% |
| 2014 FY | - CNY | 73.88% |
| 2013 FY | - CNY | 0.0% |